TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees July 29, 1988
TCL Archive FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic September 10, 1976
TCL Archive In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay June 3, 1977
